A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer
PHASE1
The primary purpose of this study is to evaluate the tolerability and safet...
A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants
PHASE1
This study will have three parts: Part A, Part B, and Part C. The primary p...
Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants
PHASE1
The primary purpose of the study is to evaluate the effects of mild and mod...
A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion
PHASE2
The primary purpose of the study is to assess the objective response rate (...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College